or a tautomer thereof or a pharmaceutically acceptable salt of the compound or tautomer,

wherein:

R₁ is selected from H and halo;

R₂ is selected from H, halo, C_1-6 alkyl, C_1-4 haloalkyl, and OR^a1;

R₃ is selected from H, C_1-6 alkyl, and C_1-4 haloalkyl;

W is selected from N and CR₄;

R₄ is selected from H, halo, OR^a2, SR^a2, 5-6 membered heterocycloalkyl, S(O)₂R^b2, C_1-6 alkyl, C_1-4 alkylthio, and C_2-6 alkenyl, wherein the C_1-6 alkyl is optionally substituted with a substituent selected from OR^a2;

R₅ is selected from H, halo, C_1-6 alkyl, and C_2-6 alkenyl, wherein the C_1-6 alkyl is optionally substituted with a substituent selected from OR^a2;

R₆ is selected from H, C_1-6 alkyl, and C_2-6 alkenyl, wherein the C_1-6 alkyl is optionally substituted with OR^a3;

R₇ is selected from H and C_1-6 alkyl; or

R₆ and R₇ together with the carbon atoms to which they are attached and the nitrogen atom connecting the two carbon atoms forms a ring of the formula:

R₈ is selected from H, C_1-6 alkyl, and C_1-4 haloalkyl;

X is selected from O and NR^N;

R^N is selected from H and C_1-4 alkyl;

R_A is H;

R_B is H; or

R_A and R_B together with the nitrogen atom to which they are attached form a 5- to 6-membered heterocycloalkyl ring containing 1 or 2 heteroatoms selected from N, O and S, wherein the 5- to 6-membered heterocycloalkyl is optionally substituted with halo;

R₉ is selected from C_1-6 alkyl, C_2-6 alkenyl, C_3-5 cycloalkyl, wherein the C_1-6 alkyl is optionally substituted with a substituent selected from OR^a3 and SR^a3;

R₁₀ is selected from H, C_2-4 alkenyl, C_1-4haloalkyl and C_1-4 alkyl optionally substituted with a substituent selected from amino, C_1-4 alkoxy, C_3-5 cycloalkyl, and 3- to 6-membered heterocycloalkyl;

R₁₁ is H or C_1-3 alkyl, wherein the C_1-3 alkyl is optionally substituted with OH; and

each of R^a1, R^a2, R^a3, and R^b2 is independently selected from H, C_1-6 alkyl and C_1-4 haloalkyl;